Janney Montgomery Scott
ACIU icon

Janney Montgomery Scott’s AC Immune ACIU Stock Holding History

Janney Montgomery Scott’s Portfolio ACIU Stock Details ACIU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-16,066
Closed -$206K – 1935
2017
Q4 		$206K Buy
16,066
+4,066
+34% +$47.9K ﹤0.01% 1785
2017
Q3 		$134K Buy
+12,000
New +$103K ﹤0.01% 1769

Other funds holding ACIU

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Janney Montgomery Scott's ACIU Position: Q1 2018 in Review

Janney Montgomery Scott sold out of AC Immune (ACIU) in Q1 2018, closing a stake of 16,066 shares — an estimated $206K sold.

Janney Montgomery Scott first reported a position in ACIU in Q3 2017 and held it in 2 quarters. The position peaked at $206K in Q4 2017. 18 funds tracked by Wall St. Rank hold ACIU as of Q1 2018.

  • Janney Montgomery Scott reported no remaining AC Immune position as of Q1 2018 after selling out during the quarter.
  • Janney Montgomery Scott sold 16,066 AC Immune shares in Q1 2018, an estimated $206K.
  • Janney Montgomery Scott first reported a position in AC Immune in Q3 2017 and held it in 2 quarters.
  • Janney Montgomery Scott's AC Immune position peaked at $206K in Q4 2017.
  • 18 funds tracked by Wall St. Rank held AC Immune as of Q1 2018.

Based on Janney Montgomery Scott's 13F filing for Q1 2018, filed 19 Apr 2018.